title: Semiparametric inference on the absolute risk reduction and the restricted mean survival difference.
abstract: For time-to-event data, when the hazards are non-proportional, in addition to the hazard ratio, the absolute risk reduction and the restricted mean survival difference can be used to describe the time-dependent treatment effect. The absolute risk reduction measures the direct impact of the treatment on event rate or survival, and the restricted mean survival difference provides a way to evaluate the cumulative treatment effect. However, in the literature, available methods are limited for flexibly estimating these measures and making inference on them. In this article, point estimates, pointwise confidence intervals and simultaneous confidence bands of the absolute risk reduction and the restricted mean survival difference are established under a semiparametric model that can be used in a sufficiently wide range of applications. These methods are motivated by and illustrated for data from the Women's Health Initiative estrogen plus progestin clinical trial.
authors: Office of Biostatistics Research, National Heart, Lung, and Blood Institute, 6701 Rockledge Dr. MSC 7913, Bethesda, MD 20892, USA. yangso@nhlbi.nih.gov
authors: Song
authors: S
authors: Yang
mesh_terms: D016001:Confidence Intervals; D003327:Coronary Disease / Q000517:prevention & control; D004359:Drug Therapy, Combination; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D015233:Models, Statistical; D011372:Progestins / Q000008:administration & dosage; D018570:Risk Assessment / Q000706:statistics & numerical data; D020521:Stroke / Q000517:prevention & control; D016019:Survival Analysis; D061665:Time-to-Treatment; D020246:Venous Thrombosis / Q000517:prevention & control
chemical_list: D011372:Progestins
references: Biometrics. 2011 Mar;67(1):29-38
references: 20560935
references: Biometrics. 2001 Dec;57(4):1030-8
references: 11764241
references: JAMA. 2002 Jul 17;288(3):321-33
references: 12117397
references: Stat Med. 2011 Aug 30;30(19):2409-21
references: 21611958
references: Am J Epidemiol. 2005 Sep 1;162(5):404-14
references: 16033876
references: N Engl J Med. 2003 Aug 7;349(6):523-34
references: 12904517
references: Biostatistics. 2011 Apr;12(2):354-68
references: 20860993